Explore research on health conditions that often occur alongside epilepsy, including anxiety, depression, sleep disorders, and other medical or neurological issues that can impact quality of life.
Researchers studied a new method for recognizing seizures using electroencephalogram (EEG) data, which measures electrical activity in the brain.
This study looked at epilepsy-dyskinesia syndromes (EDS), which are conditions where people experience both epilepsy and movement disorders.
Researchers examined the effects of levetiracetam, a medication used to treat epilepsy, on mental health, specifically focusing on suicidal thoughts in patients.
Researchers conducted a systematic review and network meta-analysis to compare the effectiveness of various non-drug treatments for anxiety, depression, and quality of life in people with epilepsy.
Researchers conducted a study to evaluate the effectiveness of a medication called fremanezumab in treating patients who experience migraines and also have major depressive disorder.
Researchers conducted a study to understand how effective first-line antiseizure medications (ASMs) are for children newly diagnosed with epilepsy.
Researchers investigated the use of intravenous (i/v) levetiracetam (LEV) as a first-line treatment for patients experiencing non-convulsive status epilepticus (NCSE), a serious condition where seizures occur without noticeable convulsions.
Researchers studied how problems with the glymphatic system, which helps clear waste from the brain, might affect cognitive decline in elderly patients with late-onset epilepsy (LOE) who also have chronic insomnia.
Researchers studied how depression and suicidal thoughts change over time in adults with epilepsy who initially had high scores on a depression screening tool called the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E).